HALO vs WAT · P/E 15, rev $857.7M vs P/E 32, rev $3.17B
Halozyme Therapeutics Inc (HALO) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the HALO and WAT stock pages for the full models.
Not investment advice.